Compare AXON & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXON | WAT |
|---|---|---|
| Founded | 1993 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.2B | 29.2B |
| IPO Year | 2001 | 1996 |
| Metric | AXON | WAT |
|---|---|---|
| Price | $492.00 | $299.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 17 |
| Target Price | ★ $767.85 | $386.38 |
| AVG Volume (30 Days) | 907.8K | ★ 1.0M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 0.47 |
| EPS | 1.51 | ★ 10.76 |
| Revenue | $2,779,536,000.00 | ★ $3,165,286,000.00 |
| Revenue This Year | $31.50 | $104.66 |
| Revenue Next Year | $28.95 | $10.53 |
| P/E Ratio | $332.51 | ★ $27.89 |
| Revenue Growth | ★ 33.47 | 6.99 |
| 52 Week Low | $396.41 | $275.05 |
| 52 Week High | $885.92 | $414.15 |
| Indicator | AXON | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 44.96 | 39.40 |
| Support Level | $403.48 | $281.62 |
| Resistance Level | $587.37 | $308.14 |
| Average True Range (ATR) | 20.39 | 8.68 |
| MACD | -3.81 | 1.88 |
| Stochastic Oscillator | 10.34 | 42.88 |
Axon Enterprise Inc is building a public safety operating system by integrating a suite of hardware devices and cloud software solutions. The company's suite includes cloud-hosted digital evidence management solutions, productivity and real-time operations software, body cameras, in-car cameras, TASER energy devices, drones and robotic security, and training solutions. The company's operation comprises of two operating segments, Software and Sensors, and TASER. The company generates the majority of its revenue from the Software and Sensors segment, which is engaged in developing, manufacturing, and selling fully integrated hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.